Several international experts have described Denmark’s decision to stop using the Astrazeneca vaccine as responsible and brave, but say it comes with the risk of another wave of the epidemic and sends a poor signal to the rest of the world.
The Danish Health Authority decided to suspend the use of the corona vaccine developed by Astrazeneca due to the risk of blood clots.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.